Description
Nystatin Tablet
Nystatin Vaginal Tablets BP / IP / USP (100,000 IU)
Healthy Life Pharma Private Limited, alongside our specialized global marketing and export division Healthy Inc, is a premier manufacturer, supplier, and exporter of advanced gynecology, women’s health, and anti-infective therapeutics. We manufacture ultra-high-purity, kinetically stable Nystatin Vaginal Tablets inside our WHO–GMP certified, environmental-hazard-controlled solid dosage manufacturing facilities. This localized, targeted “Polyene Antifungal Therapy” serves as a high-volume strategic export to maternity medical centers, public health ministries, institutional tenders, and international B2B wholesale marketplaces across Africa, the CIS region, LATAM, and South-East Asia.
Product Overview
This formulation operates as an “Ocular Fungal Membrane Puncturer.” It ensures patient safety by acting completely locally within the vaginal vault, destroying pathogenic yeast structures without systemic chemical absorption or hepatic metabolic strain.
Mechanism 1 (Ergosterol Binding): Nystatin physically binds to ergosterol, an essential sterol component residing specifically in the cell membranes of pathogenic fungi like Candida albicans.
Mechanism 2 (Pore Formation & Leakage): This physical binding chemically alters the permeability of the fungal cell wall, creating micro-pores. These pores physically allow the leakage of internal cellular potassium, inorganic phosphates, and vital low-molecular-weight phosphorus compounds.
Mechanism 3 (Fungicidal Destruction): By physically destroying the integrity of the protective fungal membrane, the formulation chemically induces cell lysis, rapidly clearing the localized infection and halting symptoms of vaginal discharge, burning, and pruritus (itching).
Product Composition & Configuration
We supply this product in the internationally recognized standard therapeutic strength optimized for uniform, localized mucosal distribution.
| Active Ingredient | Strength (per Tablet) | Formulation Delivery System | Primary Clinical Function |
| Nystatin IP / BP / USP | 100,000 IU | Non-Effervescent Local Insert: Designed for slow physical disintegration within vaginal mucosal fluids. | The Polyene Fungicide: Eradicates superficial Candida strains locally. |
| Excipients | Pharma Grade | Modified lactose, starch, and lubricating binding agents. | The Comfort Base: Ensures non-irritating, smooth insertion profiles. |
Technical & Logistics Specifications
HS Code: 3004.20.99 (Medicaments containing antibiotics / Vaginal preparations)
CAS Number: 1400-61-9 (Nystatin)
Dosage Form: Vaginal Tablet (Pessary) — Compressed, un-coated, oval-shaped tablet engineered for local cavity insertion (Not for oral consumption).
Packaging Configurations: 10 or 14 Vaginal Tablets per Blister Strip packed in high-barrier Alu-Alu (Cold-Form Foil) or thick PVC/PVDC strips, frequently co-packaged with an ergonomic, medical-grade plastic Vaginal Applicator. Our tropicalized packaging matrices guarantee a full 36-month shelf life in hot, humid Zone IVb export environments.
Manufacturing Authority & Compliance
Non-Irritating Binder Matrix: Vaginal mucosal tissue is physically sensitive. Our manufacturing lines utilize a Hypoallergenic, Low-Friction Excipient Matrix, physically ensuring that the tablet dissolves cleanly without causing localized chemical burning or tissue inflammation.
Dehumidified Core Compression: Nystatin raw active chemical powder is highly physically unstable when exposed to ambient moisture and heat. We maintain our complete blending and high-speed tableting lines inside Specialized Environmental Suites (RH less than 30%, Temperature less than 22°C) to protect biological activity.
Total Cross-Contamination Prevention: Because antifungal production requires strict separation, our facilities operate under Dedicated Air Handling Systems (HVAC), ensuring absolute cross-contamination containment to pass rigid international B2B audits.
Primary Indications
Gynecology: Local treatment of Vulvovaginal Candidiasis (vaginal yeast infections/thrush) caused by Candida albicans and other susceptible Candida species.
Maternal Health Prophylaxis: Safe, localized clearance of vaginal thrush in pregnant patients to physically prevent neonates from contracting oral thrush during delivery.
Usage Instructions
Administration Vector: For Vaginal Insertion Only. The tablet must never be swallowed physically by mouth.
The Insertion Protocol: Using the provided plastic applicator or a clean finger, insert one tablet physically deep into the vaginal vault, ideally once daily at bedtime for 14 consecutive days.
Compliance Lifecycle: It is physically critical to continue the full 14-day treatment cycle, even during menstruation, to chemically prevent a fungal relapse. Do not discontinue use prematurely when initial clinical symptoms resolve.
Hygiene Guidance: Advise patients to wear clean, breathable cotton undergarments to physically minimize localized moisture buildup that promotes fungal colonization.
Safety Warning: LOCALIZED GYNECOLOGICAL ANTIFUNGAL. Vaginal Use Only. Not for Oral Administration. Tissue Irritation Note: If severe physical burning, redness, or localized swelling develops post-insertion, discontinue use immediately. Barrier Interaction: The excipients inside vaginal tablets may physically weaken latex condoms or diaphragms; alternative non-latex protection methods are chemically recommended during active treatment. Contraindication: Do not use in patients presenting with known hypersensitivity to Nystatin or any bonding component in the solid core matrix.
Global CDMO Services & Wholesale Supply Chain
Healthy Life Pharma Private Limited provides fully validated Third-Party Contract Manufacturing (CDMO Services) and high-volume private label production for Nystatin Vaginal Tablets (100,000 IU). Whether you are coordinating a procurement bid for a National Maternal Health Ministry Tender in Sub-Saharan Africa, supplying a network of women’s clinics in the CIS, or injecting inventory into a digital B2B Pharmaceutical Marketplace across Southeast Asia or LATAM, we deliver all required international documentation (WHO-GMP Certificate, Certificate of Pharmaceutical Product – COPP, Certificate of Analysis – COA, Stability Matrix Profiles, and Complete CTD Dossier sets) for seamless regulatory clearance.
Commercial & Bulk Procurement Inquiries:
Corporate Head Office: Mumbai, Maharashtra, India
Primary Manufacturing Base: Boisar, Maharashtra, India
WhatsApp / Direct Call: +91 7710003340
Corporate Email: info@healthyinc.co.in
